Executives On The Move: Changes at the Top for Julphar, Immunomedics and Five Prime
Executive Summary
Pharma manufacturer Juphar Gulf Pharmaceutical decides on a new CEO to drive operational transformation, and the CCO at Ipsen moves to CEO post at cancer therapy firm Immunomedics to execute company growth. In addition, protein therapeutics business Five Prime Therapeutics gains oncology industry leader as CEO.